-
1
-
Introduction to long‐term survivorship after hematopoietic cell transplantation
-
6
-
International Blood and Marrow Registries: trends on long‐term data collection
-
14
-
Long‐term follow‐up program and transplant clinic setup
-
25
-
Telemedicine in patient care of long‐term transplant survivors
-
33
-
Long‐term follow‐up calendar
-
38
-
Late effects post‐allogeneic hematopoietic stem cell transplantation
-
47
-
Late effects post‐autologous hematopoietic stem cell transplantation
-
58
-
Long‐term follow‐up of children
-
73
-
Graft‐versus‐host disease and late effects after hematopoietic stem cell transplantation
-
80
-
Screening and prevention guidelines for hematopoietic cell transplant survivors
-
92
-
Biology of survivorship after blood or marrow transplantation
-
101
-
Second malignancies
-
112
-
Anti‐infective prophylaxis, immunization and prevention of late infectious complications
-
119
-
Seasonal respiratory viral infections
-
132
-
Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation
-
140
-
Skin chronic GVHD
-
166
-
Ocular complications
-
176
-
Management of oral and dental complications
-
183
-
Thyroid disease: monitoring and management guidelines
-
189
-
Pretransplant considerations in gender, reproductive, and sexual health
-
198
-
Posttransplant Considerations in Gender, Reproductive, and Sexual Health
-
211
-
Fertility issues, fertility preservation, and pregnancy outcome in long‐term survivors
-
221
-
Sexual Dysfunction in Long‐Term Survivors
-
231
-
Late non‐infectious pulmonary complications
-
241
-
Cardiac and arterial complications
-
251
-
Cardiovascular risk factors
-
260
-
Gastrointestinal complications
-
271
-
Hepatic Complications
-
278
-
Renal complications
-
287
-
Posttransplantation bone disease: prevalence, surveillance, prevention, and management
-
300
-
Late neurologic complications
-
312
-
Neurocognitive dysfunction
-
330
-
Psychological Distress
-
337
-
Evaluation and management of fatigue in survivors of allogeneic hematopoietic stem cell transplantation
-
349
-
Social Issues
-
355
-
Health‐related quality of life in adult and pediatric survivors
-
381
-
Immunosuppressive agents and monitoring in long‐term survivors
-
393
-
Nutritional support and nutritional supplementation
-
397
-
Daily routines and healthy lifestyle guidelines
-
402
-
Prevalent psychosocial adjustment issues and solutions: lifestyle and social challenges
-
406
-
Complementary and alternative medicine in HSCT
-
413
-
Impact of adherence in outcome of long‐term survivors
-
418
-
Prominent role of allied health professionals
-
420
-
Patient reported outcomes
-
428
-
Caregivers of long‐term survivors
-
434
-
Patient's perspective: memoir of a recovered lymphomaniac
-
442
-
Appendix 1: Commonly used transplant‐related medications in long‐term survivors
-
445
-
Appendix 2: The eGVHD App
-
448
-
Index
-
i
-
Front Matter
